In its meeting yesterday, the Supervisory Board of Sartorius AG approved the recommendation by the Executive Board to submit a proposal to the Annual Shareholders’ Meeting on April 19, 2012, to pay dividends of 0.82 euro per preference share (previous year: 0.62 euro) and 0.80 euro per ordinary share (previous year: 0.60 euro). If approved, the total amount disbursed under this proposal would thus rise 32.8% to 13.8 million euros.

Furthermore, as the membership terms for the Supervisory Board of Sartorius AG are due to expire at the end of this year's Annual Shareholders’ Meeting, the Supervisory Board decided on the personnel proposals to be presented to the Annual Shareholders’ Meeting for election of shareholder representatives to the Supervisory Board.

These proposals provide for the reelection of Prof. Dr. Dres. h.c. Arnold Picot, Dr. Dirk Basting, Dr. Lothar Kappich and Prof. Dr. Gerd Krieger. Prof. Dr. Klaus Rüdiger Trützschler and Prof. Dr. Thomas Scheper are proposed for the first time for election. Prof. Dr. Trützschler has been a member of the Supervisory Board since November 2011. He had been appointed by court order after the death of Supervisory Board member Dr. Michael Schulenburg. Prof. Dr. Thomas Scheper is suggested for election after Prof. Dr. rer. nat. Dr.-Ing. E.h. Heribert Offermanns, who has been a member of the Sartorius Supervisory Board since 2000, will no longer be available to serve for a further term on the grounds of age.

Upcoming Financial Dates:

March 13, 2012 Annual press conference in Goettingen, Germany

April 19, 2012 Annual Shareholders’ Meeting in Goettingen, Germany

April 24, 2012 Publication of first-quarter figures (Jan. – March 2012)

This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

A Profile of Sartorius

The Sartorius Group is a leading international laboratory and process technology provider covering the segments of Bioprocess Solutions, Lab Products & Services and Industrial Weighing. In 2011, the technology group earned sales revenue of 733.1 million euros. Founded in 1870, the Goettingen-based company currently employs more than 5,000 persons. The major areas of activity of its Bioprocess Solutions segment cover filtration, fluid management, fermentation, cell cultivation and purification, and focus on production processes in the biopharmaceutical industry. The Lab Products & Services segment primarily manufactures laboratory instruments and consumables. Industrial Weighing concentrates on weighing, monitoring and control applications in the manufacturing processes of the food, chemical and pharma sectors. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.

Sartorius (TG:SRT)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Sartorius Charts.
Sartorius (TG:SRT)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Sartorius Charts.